Skip to content

Author

C.-Y. Yang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study.

BACKGROUND Somatostatin analogs (SSAs) and targeted therapies have shown efficacy for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in the past decades. To explore the therapeutic efficacy of SSA and targeted therapy combination, we conducted a phase I/II study to evaluate the toxicity and efficacy o...

Hui-Jen Tsai, M.-H. Chen, Cheng-Fang Hsiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.